| Previous close | N/A |
| Open | N/A |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | N/A - N/A |
| 52-week range | undefined - undefined |
| Volume | N/A |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | 267 |
| Earnings date | 27 Jul 2017 |
| Dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 67.03 |
One year on from Britain's shock vote to leave the European Union, cracks are starting to appear in the FTSE 100's rally, as concerns on both political and economic fronts saw UK shares fall for a third week in a row. The blue chip FTSE 100 index was down 0.2 percent at 7,424.13 points at its close, while mid caps were up 0.1 percent.
One year on from Britain's shock vote to leave the European Union and cracks are starting to appear in the FTSE 100's rally, as concerns on both political and economic fronts put UK shares on course for ...
Repare Therapeutics Inc. has corralled $68 million to pinpoint and exploit genetic weaknesses of tumors, an approach showing promise in emerging cancer therapies.